Trinity Capital Investment is pleased to commit $2,000,000 cap-ex line to Syncardia Systems to facilitate growth.

Trinity Capital is pleased to announce its latest investment, SynCardia Systems, Inc. a Tucson, Arizona based provider of the Total Artificial Heart. Trinity worked closely with management at SynCardia to better understand its business and financing needs leading to a creative and workable $2 MM asset backed financing solution.

SynCardia Systems, Inc. is a private company formed in 2001 to commercialize the SynCardia temporary Total Artificial Heart.

Today, with more than 850 implants, the SynCardia Total Artificial Heart is the only FDA, Health Canada and CE approved Total Artificial Heart in the world. Originally used as a permanent replacement heart, the Total Artificial Heart is currently approved as a bridge to human heart transplant for people dying from end-stage biventricular failure.   www.SynCardia.com